Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earnings Information
Arrowhead Pharmaceuticals last announced its earnings results on February 3rd, 2021. The biotechnology company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of $1.00 by $1.20. Arrowhead Pharmaceuticals has generated ($0.84) earnings per share over the last year. Arrowhead Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
Arrowhead Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earnings Estimates
2021 EPS Consensus Estimate: ($0.17)
2022 EPS Consensus Estimate: ($1.43)
Arrowhead Pharmaceuticals (NASDAQ ARWR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)